Metabolites (Jul 2022)

Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study

  • Peter Liptak,
  • Eva Baranovicova,
  • Robert Rosolanka,
  • Katarina Simekova,
  • Anna Bobcakova,
  • Robert Vysehradsky,
  • Martin Duricek,
  • Zuzana Dankova,
  • Andrea Kapinova,
  • Dana Dvorska,
  • Erika Halasova,
  • Peter Banovcin

DOI
https://doi.org/10.3390/metabo12070641
Journal volume & issue
Vol. 12, no. 7
p. 641

Abstract

Read online

Several relatively recently published studies have shown changes in plasma metabolites in various viral diseases such as Zika, Dengue, RSV or SARS-CoV-1. The aim of this study was to analyze the metabolome profile of patients during acute COVID-19 approximately one month after the acute infection and to compare these results with healthy (SARS-CoV-2-negative) controls. The metabolome analysis was performed by NMR spectroscopy from the peripheral blood of patients and controls. The blood samples were collected on 3 different occasions (at admission, during hospitalization and on control visit after discharge from the hospital). When comparing sample groups (based on the date of acquisition) to controls, there is an indicative shift in metabolomics features based on the time passed after the first sample was taken towards controls. Based on the random forest algorithm, there is a strong discriminatory predictive value between controls and different sample groups (AUC equals 1 for controls versus samples taken at admission, Mathew correlation coefficient equals 1). Significant metabolomic changes persist in patients more than a month after acute SARS-CoV-2 infection. The random forest algorithm shows very strong discrimination (almost ideal) when comparing metabolite levels of patients in two various stages of disease and during the recovery period compared to SARS-CoV-2-negative controls.

Keywords